Happy SAMBA day to all who celebrate! #AcuteMed
NCEPOD is undertaking a new study to investigate the variation and remediable factors in the process of care of patients with a learning disability who present to hospital acutely unwell. We are recruiting a multi-disciplinary group of healthcare professionals with a working interest in the care of patients with a learning disability. We are looking to identify remediable factors in the quality of care received by patient and produce a national report with recommendations to improve the quality of care provided. Case reviewers will be asked to attend meetings during which they will assess case note extracts and questionnaires and provide expert opinion on the quality of healthcare received by patients with a learning disability following an emergency admission to hospital. A training day will be held in April 2025 (date to be confirmed) at a central London location. If you are unable to make this date, training on an ad hoc basis is possible. You would typically be required to attend 4 subsequent case reviewer meetings at the NCEPOD offices in London. It is anticipated case review meetings will begin in May 2025 and will run for approximately 6 months. The data collected during these meetings will form a major part of the study’s final report. Travel expenses will be reimbursed in line with our expense claim policy. We are looking for clinicians from a wide variety of specialties, including (but not limited to) emergency, intensive care and acute medicine, general practice, surgery, general and learning disability nursing. We also welcome allied health professionals such as physiotherapists, occupational therapists, and speech and language therapists with a working interest in learning disability. We aim to recruit clinicians from different clinical grades including senior trainees (ST6 and above) and applicants should be in current clinical practice. Further information about this study including a copy of the study protocol can be found on the webpage: https://www…
@ncepod.bsky.social are looking for multidisciplinary case reviewers from specialties including #EmergencyMedicine #AcuteMed #IntensiveCare & #PrimaryCare for a study into acute care of adults with a learning disability. Great experience & v worthwhile
#ChooseGeriatics
Listen… not a big-up for another “niche”
Older people’s medicine must become mainstream. Ask @CMO_England
We need more #generalists to be older people sensitive, and more specialists to be the same.
Bedfellows: #GP #AcuteMed, #PalliativeCare to back us too
@gerisoc.bsky.social
5/5
While FST is valuable for predicting AKI, it should be used cautiously in hypovolemic patients to avoid hypotension. Future studies may explore its use with other diuretics and later AKI stages. #Nephrology #AKI #FST #FOAMed #CriticalCare #CritCareSky #MedSky #AcuteMed
4/5
The Furosemide Stress Test (FST) has proven effective in predicting AKI in children after cardiac surgery and in kidney transplant recipients, where it can predict delayed graft function. #AKI #KidneyTransplant #FST #FOAMed #CriticalCare #CritCareSky #MedSky #AcuteMed
3/5
In AKI, the Furosemide Stress Test (FST) can guide RRT timing. Low urine output after FST suggests a high risk of AKI progression. Studies show FST outperforms some biomarkers in predicting severe AKI. #Nephrology #AKI #FST #FOAMed #CritCareSky #MedSky #AcuteMed
2/5
Furosemide acts in the kidney’s loop of Henle, driving water reabsorption. In AKI, altered pharmacokinetics may lead to furosemide resistance, making it a useful tool to evaluate renal tubular function. #AKI #Furosemide #KidneyHealth #CriticalCare #FOAMed #CritCareSky #MedSky #AcuteMed
The Furosemide Stress Test (FST) helps predict AKI progression and guides clinical decisions, like the timing of renal replacement therapy. By assessing urine output after FST, it indicates kidney function and potential AKI risk. #AKI #FST #Nephrology #FOAMed #CritCareSky #MedSky #AcuteMed